Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) shares gapped up before the market opened on Wednesday . The stock had previously closed at $16.19, but opened at $17.18. Sysmex shares last traded at $17.14, with a volume of 60,310 shares traded.
Sysmex Stock Performance
The stock has a market capitalization of $10.68 billion, a P/E ratio of 30.30 and a beta of 1.14. The stock has a 50 day moving average of $16.85 and a 200 day moving average of $17.94. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.30 and a current ratio of 2.97.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last released its quarterly earnings results on Wednesday, May 14th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.04). Sysmex had a return on equity of 11.81% and a net margin of 10.56%. The business had revenue of $958.89 million during the quarter, compared to the consensus estimate of $991.22 million. Equities analysts predict that Sysmex Corporation ADR will post 0.57 EPS for the current year.
About Sysmex
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Read More
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access